Validating Liver 3D Tissue Models to Advance siRNA Therapeutic Identification
Time: 10:00 am
day: Day 1
Details:
- Utilizing 3D culture systems such as primary human hepatic spheroids (PHHS) and MPS for siRNA therapeutic identification
- Discussing the optimization of 3D cell systems to enhance their utility in siRNA drug development
- Addressing the importance of implementing human specific models to improve better target validation and therapeutic screening
